Review on flavivirus vaccine development: Proceedings of a meeting jointly organised by the World Health Organization and the Thai Ministry of Public Health, 26–27 April 2004, Bangkok, Thailand

• Published in: Vaccine Vol. 23; no. 21; pp. 2689 - 2695
• Main Authors: Hombach, J., Barrett, A.D., Cardosa, M.J., Deubel, V., Guzman, M., Kurane, I., Roehrig, J.T., Sabchareon, A., Kieny, M.P.
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Ltd 15.04.2005; Elsevier Limited
• Subjects: Antibodies, Viral - blood; Clinical Trials as Topic; Committees; Dengue fever; Dengue virus; Dengue Virus - immunology; Disease control; Flavivirus; Flavivirus - immunology; Flavivirus vaccine; Human pathogenic flaviviruses; Humans; Infections; Japanese Encephalitis Vaccines - immunology; Japanese encephalitis virus; Laboratories; Medical research; Meetings; Mortality; Mutation; Public health; Sero-epidemiological studies; Studies; Tropical diseases; Vaccines; Vector-borne diseases; Viral Vaccines - immunology; Viruses; West Nile virus - immunology; Yellow Fever Vaccine - immunology; Thailand; United States > US; Bangkok Thailand; Sero-epidemiological studies; Flavivirus vaccine; Human pathogenic flaviviruses
• ISSN: 0264-410X; 1873-2518
• DOI: 10.1016/j.vaccine.2004.11.040

In light of the continuous spread of human pathogenic flaviviruses, in particular the mosquito-transmitted species, vaccine development remains a high priority on the public health agenda. On 26–27 April 2004, a conference was held in Bangkok, Thailand, to review current status of flavivirus vaccine development and related issues, focussing on dengue (DEN) and Japanese encephalitis (JE). This event, co-sponsored by the World Health Organization (WHO) and the Thai Ministry of Public Health, reviewed the progress made with vaccine development, sero-epidemiological studies and other accompanying activities critical for vaccine development and vaccination. The considerable interest in and awareness of the flavivirus diseases and their prevention by public health decision makers, as well as the establishment of two dedicated programmes for dengue and Japanese encephalitis vaccine development raise hopes that new or improved vaccines will become available in the coming years.